XPO5 and hepatocellular carcinoma: [17–19] However, in the present study, DICER (rs3742330 and rs13078), DROSHA (rs10719 and rs6877842), RAN (rs14035) and XPO5 (rs11077) polymorphisms were not associated with the risk of HCC.